Douglas Tsao
Stock Analyst at HC Wainwright & Co.
(2.04)
# 2,717
Out of 4,814 analysts
495
Total ratings
30.93%
Success rate
-6.62%
Average return
Main Sectors:
Stocks Rated by Douglas Tsao
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Reiterates: Buy | $720 | $600.66 | +19.87% | 36 | Apr 11, 2025 | |
| PTGX Protagonist Therapeutics | Reiterates: Buy | $80 | $46.32 | +72.73% | 31 | Apr 10, 2025 | |
| EOLS Evolus | Reiterates: Buy | $27 | $10.27 | +162.90% | 27 | Apr 10, 2025 | |
| ARQT Arcutis Biotherapeutics | Reiterates: Buy | $19 | $13.53 | +40.43% | 4 | Apr 3, 2025 | |
| DARE Daré Bioscience | Reiterates: Buy | $12 | $2.95 | +306.78% | 17 | Apr 1, 2025 | |
| CABA Cabaletta Bio | Reiterates: Buy | $25 | $1.18 | +2,027.66% | 25 | Apr 1, 2025 | |
| SCPH scPharmaceuticals | Reiterates: Buy | $18 | $2.63 | +585.71% | 14 | Mar 20, 2025 | |
| IMVT Immunovant | Reiterates: Buy | $51 | $14.57 | +250.03% | 22 | Mar 19, 2025 | |
| CHRS Coherus BioSciences | Reiterates: Buy | $7 | $1.04 | +573.08% | 24 | Mar 11, 2025 | |
| NMRA Neumora Therapeutics | Reiterates: Buy | $18 | $0.66 | +2,632.66% | 7 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $54 | $20.34 | +165.49% | 14 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $105 | $35.84 | +192.97% | 22 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $18.13 | +214.40% | 26 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $8.89 | +68.73% | 15 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $5 | $1.73 | +189.02% | 14 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $53 | $35.56 | +49.04% | 4 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $3 | $1.50 | +100.00% | 16 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $3.25 | +330.77% | 16 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $46 | $27.23 | +68.93% | 23 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $14 → $12 | $7.55 | +58.94% | 22 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $10.22 | +76.13% | 17 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $118 | $42.83 | +175.51% | 14 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $81 | $30.53 | +165.31% | 23 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $13.65 | +149.08% | 15 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $3.53 | +126.63% | 9 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $0.40 | +90,397.74% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 | $0.97 | +930.72% | 5 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $23 → $10 | $28.96 | -65.47% | 7 | Dec 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $168 → $182 | $136.87 | +32.97% | 4 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $19 | $6.06 | +209.41% | 2 | Jan 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $25 → $18 | $16.61 | +8.40% | 3 | Aug 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $8 | $13.28 | -39.74% | 7 | Jun 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $52 | $25.99 | +100.08% | 2 | Jun 11, 2019 |
argenx SE
Apr 11, 2025
Reiterates: Buy
Price Target: $720
Current: $600.66
Upside: +19.87%
Protagonist Therapeutics
Apr 10, 2025
Reiterates: Buy
Price Target: $80
Current: $46.32
Upside: +72.73%
Evolus
Apr 10, 2025
Reiterates: Buy
Price Target: $27
Current: $10.27
Upside: +162.90%
Arcutis Biotherapeutics
Apr 3, 2025
Reiterates: Buy
Price Target: $19
Current: $13.53
Upside: +40.43%
Daré Bioscience
Apr 1, 2025
Reiterates: Buy
Price Target: $12
Current: $2.95
Upside: +306.78%
Cabaletta Bio
Apr 1, 2025
Reiterates: Buy
Price Target: $25
Current: $1.18
Upside: +2,027.66%
scPharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $18
Current: $2.63
Upside: +585.71%
Immunovant
Mar 19, 2025
Reiterates: Buy
Price Target: $51
Current: $14.57
Upside: +250.03%
Coherus BioSciences
Mar 11, 2025
Reiterates: Buy
Price Target: $7
Current: $1.04
Upside: +573.08%
Neumora Therapeutics
Mar 7, 2025
Reiterates: Buy
Price Target: $18
Current: $0.66
Upside: +2,632.66%
Mar 4, 2025
Reiterates: Buy
Price Target: $54
Current: $20.34
Upside: +165.49%
Mar 3, 2025
Maintains: Buy
Price Target: $120 → $105
Current: $35.84
Upside: +192.97%
Mar 3, 2025
Reiterates: Buy
Price Target: $57
Current: $18.13
Upside: +214.40%
Feb 27, 2025
Reiterates: Buy
Price Target: $15
Current: $8.89
Upside: +68.73%
Feb 26, 2025
Reiterates: Neutral
Price Target: $5
Current: $1.73
Upside: +189.02%
Feb 24, 2025
Reiterates: Buy
Price Target: $53
Current: $35.56
Upside: +49.04%
Feb 18, 2025
Maintains: Buy
Price Target: $30 → $3
Current: $1.50
Upside: +100.00%
Feb 13, 2025
Reiterates: Buy
Price Target: $14
Current: $3.25
Upside: +330.77%
Feb 13, 2025
Reiterates: Neutral
Price Target: $46
Current: $27.23
Upside: +68.93%
Feb 12, 2025
Reiterates: Neutral
Price Target: $14 → $12
Current: $7.55
Upside: +58.94%
Feb 11, 2025
Reiterates: Buy
Price Target: $18
Current: $10.22
Upside: +76.13%
Jan 21, 2025
Reiterates: Buy
Price Target: $118
Current: $42.83
Upside: +175.51%
Jan 13, 2025
Reiterates: Buy
Price Target: $81
Current: $30.53
Upside: +165.31%
Dec 17, 2024
Reiterates: Buy
Price Target: $34
Current: $13.65
Upside: +149.08%
Nov 7, 2024
Reiterates: Buy
Price Target: $8
Current: $3.53
Upside: +126.63%
Oct 1, 2024
Reiterates: Buy
Price Target: $360
Current: $0.40
Upside: +90,397.74%
Jun 7, 2022
Downgrades: Neutral
Price Target: $10
Current: $0.97
Upside: +930.72%
Dec 9, 2021
Maintains: Neutral
Price Target: $23 → $10
Current: $28.96
Upside: -65.47%
Feb 20, 2020
Maintains: Equal-Weight
Price Target: $168 → $182
Current: $136.87
Upside: +32.97%
Jan 23, 2020
Downgrades: Neutral
Price Target: $19
Current: $6.06
Upside: +209.41%
Aug 29, 2019
Maintains: Underweight
Price Target: $25 → $18
Current: $16.61
Upside: +8.40%
Jun 11, 2019
Initiates: Underweight
Price Target: $8
Current: $13.28
Upside: -39.74%
Jun 11, 2019
Initiates: Overweight
Price Target: $52
Current: $25.99
Upside: +100.08%